Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine. — Lieve Naesens (1992) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine.
Shared by
De Clercq Erik
KU Leuven
Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine.
Article
1992
en
Authors
LN
Lieve Naesens
JB
Jan Balzarini
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1995
Pharmacokinetics in mice of bis(POM)-PMEA, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine
Lieve Naesens
,
J. Neytst
,
Jan Balzarini
,
N. Bischofberger
,
De Clercq Erik
Article
1991
Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo
Lieve Naesens
,
Jan Balzarini
,
De Clercq Erik
Article
1991
Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound.
Jan Balzarini
,
Hao Zhang
,
Piet Herdewijn
,
David G. Johns
,
De Clercq Erik
Article
1989
Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent.
Jan Balzarini
,
Lieve Naesens
,
Piet Herdewijn
,
Ivan Rosenberg
,
Antonı́n Holý
,
Rudi Pauwels
,
Masanori Baba
,
David G. Johns
,
De Clercq Erik
Article
1990
Anti‐retrovirus activity of 9‐(2‐phosphonylmethoxyethyl)adenine (pmea) <i>in vivo</i> increases when it is less frequently administered
Jan Balzarini
,
Lieve Naesens
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.